TNXP — Tonix Pharmaceuticals Holding Corp · rev $20.4M

Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.

Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.

Use this TNXP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TNXP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TNXP SEC filings page. Lician reads the product cache first so this HTML stays unique to Tonix Pharmaceuticals Holding Corp even when a live quote feed is slow.

Tonix Pharmaceuticals Holding Corp latest statements (FY2025)

Latest cached year on this hub. Full TNXP income, balance, and cash tables.

  • Revenue$13.1M
  • Net Income-$124.0M
  • Total Assets$277.2M
  • Total Debt$0
  • Free Cash Flow-$103.2M

TNXP recent filings